Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind Comparative Randomized Trial to Evaluate the Safety and Efficacy of the Drug Miotox® in Children with Cerebral Palsy

NCT06840158 is registered in ClinicalTrials.gov with Innopharm LLC as lead sponsor.

NCT NCT06840158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06840158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind Comparative Randomized Trial to Evaluate the Safety and Efficacy of the Drug Miotox® in Children with Cerebral Palsy
Lead sponsor
Innopharm LLC
Phase
Phase 3
Overall status
Completed
Start date
October 15, 2021
Completion date
June 29, 2022
Enrollment
80 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy (cp)